J A Bluestone

7.7k total citations · 3 hit papers
29 papers, 6.4k citations indexed

About

J A Bluestone is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, J A Bluestone has authored 29 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Genetics. Recurrent topics in J A Bluestone's work include T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (12 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). J A Bluestone is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (12 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). J A Bluestone collaborates with scholars based in United States, France and Hungary. J A Bluestone's co-authors include Arlene H. Sharpe, Alain Schweitzer, Frank Borriello, Elizabeth Tivol, William P. Lynch, Deborah J. Lenschow, Lesley Rhee, Benoı̂t L. Salomon, Bhagirath Singh and G S Gray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

J A Bluestone

28 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1995 2.3k citations Elizabeth Tivol, Frank Borriello et al. Immunity profile →
B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes

2000 1.7k citations Benoı̂t L. Salomon, Deborah J. Lenschow et al. Immunity profile →
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

1995 518 citations Deborah J. Lenschow, Shu‐Chuan Ho et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J A Bluestone United States	18	5.2k	1.6k	1.2k	522	460	29	6.4k
Jacques F.A.P. Miller Australia	30	5.8k 1.1×	1.4k 0.8×	728 0.6×	1.1k 2.1×	292 0.6×	61	6.8k
Brian T. Fife United States	34	4.6k 0.9×	2.3k 1.4×	979 0.8×	974 1.9×	711 1.5×	73	6.7k
Maria-Grazia Roncarolo Italy	29	4.9k 0.9×	1.1k 0.7×	957 0.8×	812 1.6×	476 1.0×	43	6.4k
Petter Höglund Sweden	38	4.6k 0.9×	1.1k 0.6×	737 0.6×	570 1.1×	371 0.8×	119	5.6k
Marcel Batten Australia	25	3.8k 0.7×	1.1k 0.7×	601 0.5×	712 1.4×	469 1.0×	40	5.5k
Frank Borriello United States	20	3.5k 0.7×	1.5k 0.9×	554 0.5×	578 1.1×	181 0.4×	28	4.5k
P S Linsley United States	21	4.9k 0.9×	1.2k 0.7×	502 0.4×	740 1.4×	340 0.7×	23	6.1k
Emma L. Masteller United States	24	2.2k 0.4×	835 0.5×	660 0.5×	666 1.3×	272 0.6×	36	3.4k
Sara A. Michie United States	41	2.3k 0.4×	632 0.4×	941 0.8×	1.3k 2.6×	813 1.8×	86	5.2k
Philip J. Lucas United States	23	4.5k 0.9×	1.1k 0.7×	353 0.3×	713 1.4×	249 0.5×	32	5.6k

Countries citing papers authored by J A Bluestone

Since Specialization

Citations

This map shows the geographic impact of J A Bluestone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Bluestone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Bluestone more than expected).

Fields of papers citing papers by J A Bluestone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Bluestone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Bluestone. The network helps show where J A Bluestone may publish in the future.

Co-authorship network of co-authors of J A Bluestone

This figure shows the co-authorship network connecting the top 25 collaborators of J A Bluestone. A scholar is included among the top collaborators of J A Bluestone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J A Bluestone. J A Bluestone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lebrec, Hervé, John Bui, Jonathan M. Clingan, et al.. (2025). Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune disease. iScience. 28(5). 112447–112447.

Chatenoud, Lucienne, et al.. (2024). The Teplizumab Saga: The Challenge of Not Getting Lost in Clinical Translation. Cold Spring Harbor Perspectives in Medicine. 15(10). a041600–a041600. 1 indexed citations

Tang, Qizhi, et al.. (2004). Distinct roles of CTLA‐4 and TGF‐β in CD4⁺CD25⁺ regulatory T cell function. European Journal of Immunology. 34(11). 2996–3005. 303 indexed citations

Wells, Andrew D., Matthew C. Walsh, J A Bluestone, & Laurence A. Turka. (2001). Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. Journal of Clinical Investigation. 108(6). 895–904. 143 indexed citations

Salomon, Benoı̂t L., Deborah J. Lenschow, Lesley Rhee, et al.. (2000). B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes. Immunity. 12(4). 431–440. 1702 indexed citations breakdown →

Karandikar, Nitin J., Carol L. Vanderlugt, J A Bluestone, & Stephen D. Miller. (1998). Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. Journal of Neuroimmunology. 89(1-2). 10–18. 46 indexed citations

Smith, Judith A. & J A Bluestone. (1997). T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs. Current Opinion in Immunology. 9(5). 648–654. 54 indexed citations

Karandikar, Nitin J., Carol L. Vanderlugt, Theresa L. Walunas, Stephen D. Miller, & J A Bluestone. (1996). CTLA-4: a negative regulator of autoimmune disease.. The Journal of Experimental Medicine. 184(2). 783–788. 323 indexed citations

Bluestone, J A. (1996). Costimulation and its role in organ transplantation. Clinical Transplantation. 10(1pt2). 104–109. 30 indexed citations

10.

Lenschow, Deborah J., Shu‐Chuan Ho, Husain Sattar, et al.. (1995). Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.. The Journal of Experimental Medicine. 181(3). 1145–1155. 518 indexed citations breakdown →

11.

Tivol, Elizabeth, Frank Borriello, Alain Schweitzer, et al.. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3(5). 541–547. 2320 indexed citations breakdown →

12.

Bluestone, J A. (1995). New perspectives of C1328-137-mediated T cell costimulation. Immunity. 2(6). 555–559. 447 indexed citations

13.

Tatsumi, Yoichi, et al.. (1993). Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage.. The Journal of Experimental Medicine. 177(4). 1061–1070. 21 indexed citations

14.

Sperling, Anne I. & J A Bluestone. (1993). The first line of defence?. Current Biology. 3(5). 294–296. 10 indexed citations

15.

Blazar, Bruce R., Patricia A. Taylor, Dale C. Snover, J A Bluestone, & Daniel A. Vallera. (1993). Nonmitogenic anti-CD3F(ab’)2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier. The Journal of Immunology. 150(1). 265–277. 40 indexed citations

16.

Lenschow, Deborah J., Gloria H. Su, L Zuckerman, et al.. (1993). Expression and functional significance of an additional ligand for CTLA-4.. Proceedings of the National Academy of Sciences. 90(23). 11054–11058. 231 indexed citations

17.

Kast, W. Martin, J A Bluestone, Mirjam H.M. Heemskerk, et al.. (1990). Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cells.. The Journal of Immunology. 145(7). 2254–2259. 24 indexed citations

18.

Evavold, Brian D., et al.. (1989). T helper 2 (T_h2) but not T_h1 clones costimulate resting T cells in the presence of anti-CD3 monoclonal antibody. International Immunology. 1(4). 443–449. 3 indexed citations

19.

Pardoll, DM, Andrew M. Lew, W L Maloy, et al.. (1987). Analysis of T-Cell Receptor Gamma Chain Expression in the Thymus. Advances in experimental medicine and biology. 225. 241–246. 1 indexed citations

20.

Bluestone, J A & Cesar A. Lopez. (1979). Suppression of the Immune Response in Tumor-Bearing Mice. II. Characterization of Adherent Suppressor Cells<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 63(5). 1221–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact